Top

Journal of Ophthalmic Inflammation and Infection

Published in:

Open Access 01-12-2016 | Brief report

Dexamethasone intravitreal implants in the management of tubercular multifocal serpiginoid choroiditis

Authors: Alex Fonollosa, Sonia Valsero, Joseba Artaraz, Ioana Ruiz-Arruza

Published in: Journal of Ophthalmic Inflammation and Infection | Issue 1/2016

Abstract

Background

Continuous progression of lesions despite an adequate treatment has been described in tubercular multifocal serpiginoid choroiditis. Reported treatments for this paradoxical response include systemic steroids, immunosuppressive drugs, and intravitreal methotrexate. We describe the use of dexamethasone intravitreal implants in a patient presenting with this condition.

Findings

A 46-year-old woman sought medical attention for scotomas in her left eye. Tests suggested multifocal serpiginoid choroiditis associated with latent tuberculosis infection, and hence, she was started on anti-tuberculosis drugs in combination with corticosteroids. Given that lesions progressed despite this treatment, we began treatment with dexamethasone intravitreal implants. After injection of the second implant, we succeeded in inactivating the inflammatory process.

Conclusions

Dexamethasone intravitreal implants may be a suitable alternative to systemic steroids or immunosuppressive therapy in the management of continuous progression of lesions in tubercular multifocal serpiginoid choroiditis.

Bansal R, Gupta A, Gupta V, Dogra MR, Sharma A, Bambery P (2012) Tubercular serpiginous-like choroiditis presenting as multifocal serpiginoid choroiditis. Ophthalmology 119:2334–2342CrossRefPubMed

Moreno C, Taverne J, Mehlert A, Bate CA, Brealey RJ, Meager A, Rook GA, Playfair JH (1989) Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. Clin Exp Immunol 76:240–245PubMedPubMedCentral

McAllister WA, Thompson PJ, Al-Habet SM, Rogers HJ (1983) Rifampicin reduces effectiveness and bioavailability of prednisolone. Br Med J (Clin Res Ed) 286:923–925CrossRef

Gupta V, Bansal R, Gupta A (2011) Continuous progression of tubercular serpiginous-like choroiditis after initiating antituberculosis treatment. Am J Opthalmol 152:857–863CrossRef

Basu S, Nayak S, Padhi TR, Das T (2013) Progressive ocular inflammation following anti-tubercular therapy for presumed ocular tuberculosis in a high-endemic setting. Eye 27:657–662CrossRefPubMedPubMedCentral

Julian K, Langner-Wegscheider BJ, Haas A, De Smet MD (2013) Intravitreal methotrexate in the management of presumed tuberculous serpiginous-like choroiditis. Retina 33:1943–1948CrossRefPubMed

Zarranz-Ventura J, Carreño E, Johnston RL, Mohammed Q, Ross AH, Barker C, Fonollosa A, Artaraz J, Pelegrin L, Adan A, Lee RW, Dick AD, Sallam A (2014) Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency. Am J Ophthalmol 158:1136–1145.e5CrossRefPubMed

Fonollosa A, Llorenç V, Artaraz J, Jimenez B, Ruiz-Arruza I Agirrebengoa K, Cordero-Coma M, Costales-Mier F, Adan A (2016) Safety and efficacy of intravitreal dexamethasone implants in the management of macular edema secondary to infectious uveitis. Retina. Epub ahead of print

Portero A, Careño E, Real LA, Villaron S, Herreras JM (2012) Infectious nontuberculous serpiginous choroiditis. Arch Ophthalmol 130:1207–1208CrossRefPubMed

Title: Dexamethasone intravitreal implants in the management of tubercular multifocal serpiginoid choroiditis
Authors: Alex Fonollosa
Sonia Valsero
Joseba Artaraz
Ioana Ruiz-Arruza
Publication date: 01-12-2016
Publisher: Springer Berlin Heidelberg
Published in: Journal of Ophthalmic Inflammation and Infection / Issue 1/2016
Electronic ISSN: 1869-5760
DOI: https://doi.org/10.1186/s12348-016-0101-4

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Dexamethasone intravitreal implants in the management of tubercular multifocal serpiginoid choroiditis

Abstract

Background

Findings

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Findings

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2016

Spatial agreement between Goldmann visual field defects and fundus autofluorescence in patients with birdshot chorioretinopathy

Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients—case report and comprehensive review of the literature

Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis

Bilateral frosted branch angiitis as the presenting sign of antiphospholipid antibody syndrome

Efficacy and safety of topical ganciclovir in the management of cytomegalovirus (CMV)-related anterior uveitis

Comparison of clinico-microbiological profile and treatment outcome of in-house and referred post cataract surgery endophthalmitis in a tertiary care center in South India